Healthcare provider profile · identity verified

Brian D Raymaker, MD

Family Practice · ST AUGUSTINE, FL · NPI 1184696221

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	402	114
Levothyroxine Sodium	Levothyroxine Sodium	316	73
Losartan Potassium	Losartan Potassium	312	84
Atorvastatin Calcium	Atorvastatin Calcium	303	86
Rosuvastatin Calcium	Rosuvastatin Calcium	296	87
Lisinopril	Lisinopril	192	53
Hydrochlorothiazide	Hydrochlorothiazide	168	47
Metformin Hcl Er	Metformin Hcl	128	37
Tamsulosin Hcl	Tamsulosin Hcl	121	35
Simvastatin	Simvastatin	119	35
Valsartan	Valsartan	101	35
Alprazolam	Alprazolam	96	26
Omeprazole	Omeprazole	92	34
Sertraline Hcl	Sertraline Hcl	87	31
Pravastatin Sodium	Pravastatin Sodium	72	24
Pantoprazole Sodium	Pantoprazole Sodium	71	27
Fluticasone Propionate	Fluticasone Propionate	70	32
Indapamide	Indapamide	68	21
Eliquis	Apixaban	65	17
Montelukast Sodium	Montelukast Sodium	63	18
Metoprolol Succinate	Metoprolol Succinate	62	17
Myrbetriq	Mirabegron	58	16
Zolpidem Tartrate	Zolpidem Tartrate	57	11
Finasteride	Finasteride	53	15
Ezetimibe	Ezetimibe	51	17
Clopidogrel	Clopidogrel Bisulfate	50	11
Doxycycline Hyclate	Doxycycline Hyclate	50	39
Metoprolol Tartrate	Metoprolol Tartrate	50	20
Potassium Chloride	Potassium Chloride	48	18
Metformin Hcl	Metformin Hcl	47	13
Trazodone Hcl	Trazodone Hcl	46	14
Carvedilol	Carvedilol	43	12
Albuterol Sulfate Hfa	Albuterol Sulfate	42	20
Ozempic	Semaglutide	42	suppressed
Allopurinol	Allopurinol	41	13
Glimepiride	Glimepiride	38	suppressed
Mounjaro	Tirzepatide	37	suppressed
Bumetanide	Bumetanide	35	13
Synthroid	Levothyroxine Sodium	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Lorazepam	Lorazepam	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Methylprednisolone	Methylprednisolone	30	20
Alendronate Sodium	Alendronate Sodium	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	19
Labetalol Hcl	Labetalol Hcl	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Lovastatin	Lovastatin	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Famotidine	Famotidine	24	suppressed
Atenolol	Atenolol	22	suppressed
Gabapentin	Gabapentin	22	suppressed
Meloxicam	Meloxicam	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Eszopiclone	Eszopiclone	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Farxiga	Dapagliflozin Propanediol	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Prednisone	Prednisone	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Cephalexin	Cephalexin	15	12
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Klor-Con 10	Potassium Chloride	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cialis	Tadalafil	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error